Baselmans AH, Koten JW, Battermann JJ, Van Dijk JE, Den Otter W (2002) The mechanism of regression of solid SL2 lymphosarcoma after local IL-2 therapy. Cancer Immunol Immunother 51:492
Article
Google Scholar
Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (1992) American Joint Committee on Cancer: manual for staging of cancer, p 33
Google Scholar
Chan ATC, Leo PML, Johnson PJ (2002) Nasopharyngeal carcinoma. Ann Oncol 13:1007
Article
Google Scholar
Chi KH, Meyers JN, Chow KC, Chan WK, Tsang YW, Chao Y, Yen SH, Lotze MT (2001) Phase II trial of systemic recombinant interleukin-2 in the treatment of refractory nasopharyngeal carcinoma. Oncology 60:110
Article
Google Scholar
Cortesina G, De Stefani A, Galeazzi E, Cavallo GP, Jemma C, Giovarelli M, Vai S, Forni G (1991) Interleukin-2 injected around tumor-draining lymph nodes in head and neck cancer. Head Neck 13:125
CAS
PubMed
Google Scholar
De Mik HJ, Koten JW, Maas RA, Dullens HF, Den Otter W (1991) Tumour regression by IL-2 mediated stagnation of blood flow. In Vivo 5:679
Google Scholar
Den Otter W, Cadee J, Gavhumende R, De Groot CJ, Hennink WE, Stewart R (1999) Effective cancer therapy with a single injection of interleukin-2 at the site of the tumour. Cancer Immunol Immunother 48:419
Article
Google Scholar
Den Otter W, Dobrowolski Z, Bugajski A, Papla B, Van Der Meijden APM, Koten JW, Boon TA, Siedlar M, Zembala M (1998) Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients. J Urol 159:1183
Article
Google Scholar
Den Otter W, Hill FWG, Klein WR, Koten JW, Steerenberg PA, De Mulder PHM, Rhode C, Stewart R, Faber JA, Ruitenberg EJ, Rutten VPMG (1995) Therapy of bovine ocular squamous-cell carcinoma with local doses of interleukin-2: 67% complete regressions after 20 months of follow-up. Cancer Immunol Immunother 41:10
Article
Google Scholar
Den Otter W, Maas RA, Koten JW, Dullens HFJ, Bernsen M, Klein WR, Rutten VPMG, Steerenberg PA, Balemans L, Ruitenberg EJ et al (1991) Effective immunotherapy with local low doses of interleukin-2. In Vivo 5:561
Google Scholar
Edwards M, Miller F, Sims D, Abney D, Schuschke D, Corey T (1992) Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage. Cancer Res 52:3425
Google Scholar
Edwards M, Schuschke D, Abney D, Miller F (1991) Interleukin-2 acutely induces protein leakage from the microcirculation. J Surg Res 50:609
Article
Google Scholar
Farias TP, Dias FL, Lima RA, Kligerman J, de Sa GM, Barbosa MM, Goncalves FBJ (2003) Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 129:794
Article
Google Scholar
Harada Y, Yahara I (1993) Pathogenesis of toxicity with human-derived interleukin-2 in experimental animals. Int Rev Exp Pathol 34:37
Google Scholar
Jacobs JJL, Sparendam D, Den Otter W (2005) Local interleukin 2 therapy is most effective against cancer when injected intratumourally. Cancer Immunol Immunother (in press)
Jurgenliemk-Schulz IM, Renes IB, Rutgers DH, Everse LA, Bernsen MR, Den Otter W, Battermann JJ (1997) Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2). Radiat Oncol Investig 5:54
Article
Google Scholar
Koukourakis MI, Whitehouse RM, Giatromanolaki A, Saunders M, Kaklamanis L (1996) Predicting distant failure in nasopharyngeal cancer. Laryngoscope 106:765
Article
Google Scholar
Krastev Z, Koltchakov V, Popov D, Alexiev A, Koten J-W, Den Otter W (2003) A case of hepatocellular carcinoma (HCC): treatment with local application of alcohol and interleukin 2 (IL-2). Cancer Immunol Immunother 50:1647
Google Scholar
Krastev Z, Koltchakov V, Vladov N, Popov D, Milev A, Koten JW, Den Otter W (2001) A mesothelioma that is sensitive to locally applied IL-2. Cancer Immunol Immunother 50:226
Article
Google Scholar
Kusnierczyk H, Pajtasz-Piasecka E, Koten J-W, Bijleveld C, Krawczyk KP, Den Otter W (2004) Multiple versus single IL-2 treatment of transplanted murine colon carcinoma. Cancer Immunol Immunother 53:445
Article
Google Scholar
Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY (2003) Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 21:631
Article
Google Scholar
Maas RA, Dullens HFJ, De Jong WH, Den Otter W (1989) Immunotherapy of mice with a large burden of disseminated lymphoma with low-dose interleukin 2. Cancer Res 49:7037
Google Scholar
Marks JE, Phillips JL, Menck HR (1998) The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 83:582
Article
PubMed
Google Scholar
Mould RF, Tai THP (2002) Nasopharyngeal carcinoma: treatments and outcomes in the 20th century. Br J Radiol 75:307
CAS
PubMed
Google Scholar
Reddy SP, Raslan WF, Gooneratne S, Kathuria S, Marks JE (1995) Prognostic significance of keratinization in nasopharyngeal carcinoma. Am J Otolaryngol 16:103
Article
Google Scholar
Rosenblatt E, Brook OR, Erlich N, Miller B, Joachims HZ, Kuten A (2003) Late visual and auditory toxicity of radiotherapy for nasopharyngeal carcinoma. Tumori 89:68
Google Scholar
Rosenstein M, Ettinghausen SE, Rosenberg SA (1986) Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. J Immunol 137:1735
Google Scholar
Shanmugaratnam K, Sobin L (eds) (1978) Histological typing of upper respiratory tract tumors, p 32
Yu MC, Yuan J-M (2002) Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12:421
Article
Google Scholar